Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants

Gaucher disease is a common lysosomal storage disease caused by a defect of acid β-glucosidase (GCase). The optimal in vitro hydrolase activity of GCase requires saposin C, an activator protein that derives from a precursor, prosaposin. To develop additional models of Gaucher disease and to test in...

Full description

Bibliographic Details
Main Authors: Ying Sun, Brian Quinn, David P. Witte, Gregory A. Grabowski
Format: Article
Language:English
Published: Elsevier 2005-10-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520329011
_version_ 1818732245380235264
author Ying Sun
Brian Quinn
David P. Witte
Gregory A. Grabowski
author_facet Ying Sun
Brian Quinn
David P. Witte
Gregory A. Grabowski
author_sort Ying Sun
collection DOAJ
description Gaucher disease is a common lysosomal storage disease caused by a defect of acid β-glucosidase (GCase). The optimal in vitro hydrolase activity of GCase requires saposin C, an activator protein that derives from a precursor, prosaposin. To develop additional models of Gaucher disease and to test in vivo effects of saposin deficiencies, mice expressing low levels (4–45% of wild type) of prosaposin and saposins (PS-NA) were backcrossed into mice with specific point mutations (V394L/V394L or D409H/D409H) of GCase. The resultant mice were designated 4L/PS-NA and 9H/PS-NA, respectively. In contrast to PS-NA mice, the 4L/PS-NA and 9H/PS-NA mice displayed large numbers of engorged macrophages and nearly exclusive glucosylceramide (GC) accumulation in the liver, lung, spleen, thymus, and brain. Electron microscopy of the storage cells showed the characteristic tubular storage material of Gaucher cells. Compared with V394L/V394L mice, 4L/PS-NA mice that expressed 4–6% of wild-type prosaposin levels had ∼25–75% decreases in GCase activity and protein in liver, spleen, and fibroblasts.These results imply that reduced saposin levels increased the instability of V394L or D409H GCases and that these additional decreases led to large accumulations of GC in all tissues. These models mimic a more severe Gaucher disease phenotype and could be useful for therapeutic intervention studies.
first_indexed 2024-12-17T23:30:30Z
format Article
id doaj.art-0dd6aaaa7e6743ca9313a86451696f23
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T23:30:30Z
publishDate 2005-10-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-0dd6aaaa7e6743ca9313a86451696f232022-12-21T21:28:40ZengElsevierJournal of Lipid Research0022-22752005-10-01461021022113Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variantsYing Sun0Brian Quinn1David P. Witte2Gregory A. Grabowski3Division and Program in Human Genetics, Children's Hospital Research Foundation, Cincinnati, OH 45229-3039Division and Program in Human Genetics, Children's Hospital Research Foundation, Cincinnati, OH 45229-3039Division of Pediatric Pathology, Children's Hospital Research Foundation, Cincinnati, OH 45229-3039To whom correspondence should be addressed.; Division and Program in Human Genetics, Children's Hospital Research Foundation, Cincinnati, OH 45229-3039Gaucher disease is a common lysosomal storage disease caused by a defect of acid β-glucosidase (GCase). The optimal in vitro hydrolase activity of GCase requires saposin C, an activator protein that derives from a precursor, prosaposin. To develop additional models of Gaucher disease and to test in vivo effects of saposin deficiencies, mice expressing low levels (4–45% of wild type) of prosaposin and saposins (PS-NA) were backcrossed into mice with specific point mutations (V394L/V394L or D409H/D409H) of GCase. The resultant mice were designated 4L/PS-NA and 9H/PS-NA, respectively. In contrast to PS-NA mice, the 4L/PS-NA and 9H/PS-NA mice displayed large numbers of engorged macrophages and nearly exclusive glucosylceramide (GC) accumulation in the liver, lung, spleen, thymus, and brain. Electron microscopy of the storage cells showed the characteristic tubular storage material of Gaucher cells. Compared with V394L/V394L mice, 4L/PS-NA mice that expressed 4–6% of wild-type prosaposin levels had ∼25–75% decreases in GCase activity and protein in liver, spleen, and fibroblasts.These results imply that reduced saposin levels increased the instability of V394L or D409H GCases and that these additional decreases led to large accumulations of GC in all tissues. These models mimic a more severe Gaucher disease phenotype and could be useful for therapeutic intervention studies.http://www.sciencedirect.com/science/article/pii/S0022227520329011macrophagelysosomal storage diseaseglycosphingolipids
spellingShingle Ying Sun
Brian Quinn
David P. Witte
Gregory A. Grabowski
Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants
Journal of Lipid Research
macrophage
lysosomal storage disease
glycosphingolipids
title Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants
title_full Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants
title_fullStr Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants
title_full_unstemmed Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants
title_short Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants
title_sort gaucher disease mouse models point mutations at the acid β glucosidase locus combined with low level prosaposin expression lead to disease variants
topic macrophage
lysosomal storage disease
glycosphingolipids
url http://www.sciencedirect.com/science/article/pii/S0022227520329011
work_keys_str_mv AT yingsun gaucherdiseasemousemodelspointmutationsattheacidbglucosidaselocuscombinedwithlowlevelprosaposinexpressionleadtodiseasevariants
AT brianquinn gaucherdiseasemousemodelspointmutationsattheacidbglucosidaselocuscombinedwithlowlevelprosaposinexpressionleadtodiseasevariants
AT davidpwitte gaucherdiseasemousemodelspointmutationsattheacidbglucosidaselocuscombinedwithlowlevelprosaposinexpressionleadtodiseasevariants
AT gregoryagrabowski gaucherdiseasemousemodelspointmutationsattheacidbglucosidaselocuscombinedwithlowlevelprosaposinexpressionleadtodiseasevariants